Genetic tests

non-Belgian patients
| Phenotype/ Clinical indication |
Test |
OMIM (gene ID) |
Exons/Amplicons |
Technique |
Turnaround time (months) |
Price (Euro) |
Dementia |
| |
PSEN1 |
104311 |
3 - 12 |
PCR+sequencing |
3 |
400 |
| |
APP |
104760 |
16 - 17 |
PCR+sequencing |
3 |
400 |
| Alzheimer dementia (AD) |
| |
PSEN1 |
104311 |
3 - 12 |
PCR+sequencing |
3 |
400 |
| |
APP |
104760 |
16 - 17 |
PCR+sequencing |
3 | 400 |
| |
APP duplication |
104760 |
gen dosage |
MAQ |
3 |
400 |
| |
APP promotor |
104760 |
2 amplicons |
PCR+sequencing |
3 |
400 |
| |
PGRN |
138945 |
2 - 13 |
PCR+sequencing |
3 |
500 |
| Familial Alzheimer dementia |
| |
PSEN1 |
104311 |
3 - 12 |
PCR+sequencing |
3 |
400 |
| |
APP |
104760 |
16 - 17 |
PCR+sequencing |
3 |
400 |
| |
APP duplication |
104760 |
gen dosage |
MAQ |
3 |
400 |
| |
PSEN2 |
600759 |
3 - 12 |
PCR+sequencing |
6 |
400 |
| |
MAPT |
157140 |
1, 9 - 13 |
PCR+sequencing |
3 |
400 |
| |
PRNP |
176640 |
1 (3 amplicons) |
PCR+sequencing |
3 |
400 |
| Alzheimer mutation carriers |
| |
APOE genotype |
107741 |
1 |
PCR+sequencing |
3 |
200 |
| Cerebral amyloid angiopathy (CAA) |
| |
APP |
104760 |
16 - 17 |
PCR+sequencing |
3 |
400 |
| |
APP duplication |
104760 |
gen dosage |
MAQ |
3 |
400 |
| |
APP promotor |
104760 |
2 amplicons |
PCR+sequencing |
3 |
400 |
| Frontotemporal lobar degeneration (FTLD) |
| |
PGRN |
138945 |
13 - 2 |
PCR+sequencing |
3 |
500 |
| |
C9orf72 repeat |
614260 |
repeat expansie |
PCR+sequencing |
3 |
400 |
| |
MAPT |
157140 |
1, 9 - 13 |
PCR+sequencing |
3 |
400 |
| |
VCP |
601023 |
3 17 |
PCR+sequencing |
6 |
600 |
| |
CHMP2B |
609512 |
1 - 6 |
PCR+sequencing |
6 |
400 |
| Parkinsons disease (PD) |
| |
LRRK2 |
609007 |
24,25,29,30,31,35,41 |
PCR+sequencing |
3 |
400 |
| |
PARK2 |
602544 |
1 - 12 |
PCR+sequencing |
3 |
500 |
| |
PARK2 dosage |
602544 |
exon dosage |
MAQ + QPCR |
3 |
900 |
| |
SNCA |
163890 |
2 - 6 |
PCR+sequencing |
3 |
400 |
| |
SNCA dosage |
163890 |
gene dosage |
QPCR |
3 |
400 |
| |
PINK1 |
608309 |
1 - 8 |
PCR+sequencing |
6 |
400 |
| |
DJ1 |
602533 |
2 - 6 |
PCR+sequencing |
6 |
400 |
| Amyotrophic lateral sclerosis (ALS) |
| |
C9orf72 repeat |
614260 |
repeat expansie |
PCR+sequencing |
3 |
400 |
| |
SOD1 |
147450 |
41030 |
PCR+sequencing |
6 |
400 |
| |
TARDBP |
605078 |
2 – 6 |
PCR+sequencing |
6 |
400 |
| |
FUS |
137070 |
42005 |
PCR+sequencing |
6 |
600 |
| Prion diseases (CJD/GSS/FFI) |
| |
PRNP |
176640 |
1 (3 amplicons) |
PCR+sequencing |
3 |
400 |
| |
PRNP codon 129 |
176640 |
1 amplicon |
PCR+sequencing |
3 |
200 |
| Dravet syndrome, severe myoclonic epilepsy of infancy (SMEI) |
| |
SCN1A |
182389 |
1 - 26 (28 amplicons) |
PCR+sequencing |
6 |
1100 |
| |
SCN1A exon dosage |
182389 |
exon dosage |
MAQ |
6 |
600 |
| Epilepsy with febrile seizures (GEFS+) |
| |
SCN1A |
182389 |
1 - 26 (28 amplicons) |
PCR+sequencing |
6 |
1100 |
| Benign (familial) neonatal seizures (BNS/BFNS) |
| |
KCNQ2 |
602235 |
1 - 17 (18 amplicons) |
PCR+sequencing |
6 |
700 |
| GLUT1 deficiency, paroxysmal dyskinesia |
| |
SLC2A1 GLUT-1) |
138140 |
1 - 10 |
PCR+sequencing |
6 |
400 |
| Epileptic encephalopathy, Ohtahara syndrome |
| |
STXBP1 |
602926 |
1 - 20 |
PCR+sequencing |
6 |
700 |
| |
KCNQ2 |
602235 |
1 - 17 (18 amplicons) |
PCR+sequencing |
6 |
700 |
| Progressive external ophtalmoplegia (PEO), Alpers syndrome |
| |
POLG |
174763 |
2 - 23 (16 amplicons) |
PCR+sequencing |
6 |
650 |
| |
C10ORF2 (Twinkle) |
606075 |
1 - 5 (6 amplicons) |
PCR+sequencing |
6 |
400 |
| Charcot-Marie-Tooth type 1 (CMT1) |
| |
CMT1A duplication |
601097 |
CMT1A regio chr17p11.2 |
MAQ+STR |
3 |
500 |
| |
GJB1 |
304040 |
2 |
PCR+sequencing |
6 |
400 |
| |
MPZ |
159440 |
1 - 6 (5 amplicons) |
PCR+sequencing |
6 |
400 |
| |
PMP22 |
601097 |
1 - 4 |
PCR+sequencing |
6 |
400 |
| Charcot-Marie-Tooth type 2 (CMT2) |
| |
GJB1 |
304040 |
2 |
PCR+sequencing |
6 |
400 |
| |
MPZ |
159440 |
1 - 6 (5 amplicons) |
PCR+sequencing |
6 |
400 |
| |
MFN2 |
608507 |
1 - 17 (16 amplicons) |
PCR+sequencing |
6 |
650 |
| Hereditary neuropathy with liability to pressure palsies (HNPP) |
| |
HNPP deletion |
601097 |
HNPP regio chr17p11.2 |
MAQ+STR |
3 |
500 |
| |
PMP22 |
601097 |
1 - 4 |
PCR+sequencing |
6 |
400 |
| Dejerine-Sottas syndrome, congenital hypomyelinisation |
| |
CMT1A duplication |
601097 |
CMT1A regio chr17p11.2 |
MAQ+STR |
3 |
500 |
| |
MPZ |
159440 |
1 - 6 (5 amplicons) |
PCR+sequencing |
6 |
400 |
| |
PMP22 |
601097 |
1 - 4 |
PCR+sequencing |
6 |
400 |
| Hereditairy spastic paraplegia (HSP) |
| |
SPAST (SPG4) |
604277 |
1 - 17 (16 amplicons) |
PCR+sequencing |
6 |
650 |
| |
SPAST exon dosage |
604277 |
exon dosage |
MAQ |
6 |
500 |
| |
ATL1 (SPG3A) |
606439 |
1 - 14 |
PCR+sequencing |
6 |
600 |
| Known, familial mutation |
| |
|
|
|
|
1 |
200 |
| Prenatal testing |
| |
|
|
|
|
2 weeks |
200 |
| Presymptomatic testing |
| |
|
|
|
|
2 weeks |
200 |